The Effect of COVID-19 Restrictions on General and HIV Positive Inpatient Admissions and Treatment Outcomes: An Uncontrolled Before-and-after Study at a Ugandan Tertiary Hospital
Authors:
- Andrew KazibweAKAndrew Kazibwe
- Bonniface OryokotBOBonniface Oryokot
- Andrew Peter KyazzeAKAndrew Peter Kyazze
- Philip SsekamattePSPhilip Ssekamatte
- George Patrick AkabwaiGAGeorge Patrick Akabwai
- Emmanuel SerembaESEmmanuel Seremba
- David MukunyaDMDavid Mukunya
- Magid KagimuMKMagid Kagimu
- Irene Andia-BiraroIAIrene Andia-Biraro
- Robert KalyesubulaRKRobert Kalyesubula
Open Access
- 25 May 2023
- journal article
- research article
- Published by Springer Nature in AIDS and Behavior
- Vol. 27 (11) , 3745-3754
Abstract
Measures to contain the Corona Virus Disease 2019 (COVID-19) pandemic curtailed access to prevention and treatment services for endemic infectious diseases like HIV. We used an uncontrolled before-and-after study design to compare general and HIV positive (HIV+) inpatient outcomes at a tertiary hospital in Uganda, using electronic records of medical inpatients. Data was downloaded, cleaned in Microsoft Excel, and exported to STATA for analysis. We determined the difference in number of admissions and median length of hospital stay using Mann-Whitney U test; and difference in median survival and incidence rates of mortality using Kaplan – Meier statistics, between the pre- and peri-COVID-19 groups. Of 7506 patients admitted to Kiruddu NRH, 50.8% (3812) were female and 18.7% (1,401) were aged 31–40 years, and 18.8% (1,411) were HIV+. Overall, 24.6% (1849) died. Total admissions were lower (2192 vs. 5314 patients), overall mortality rate higher (41.8% vs. 17.6%, p < 0.01), median length of hospital stay longer (6 vs. 4 days, p < 0.01) and median survival shorter (11 vs. 20 days, Chi-square = 252.05, p < 0.01) in the peri- than in pre-COVID-19 period. The adjusted hazard ratio (aHR) of death was 2.08 (95% CI: 1.85–2.23, p < 0.01) in the peri- compared to the pre-COVID-19 period. These differences were more pronounced in HIV + patients. Compared to pre-COVID-19, the peri-COVID-19 period registered lower inpatient admissions but poorer treatment outcomes for general and HIV + inpatients. Emerging epidemic responses should minimize disruption to inpatient care, especially for HIV + individuals.Keywords
Funding Information
- Makerere University Research and Innovations Fund (Makerere University Research and Innovations Fund)
- Mulago Foundation (Mulago Foundation)
This publication has 27 references indexed in Scilit:
- Global drug shortages due to COVID-19: Impact on patient care and mitigation strategiesResearch in Social and Administrative Pharmacy, 2021
- Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evidenceBMC Infectious Diseases, 2020
- Lockdown measures in response to COVID-19 in nine sub-Saharan African countriesBMJ Global Health, 2020
- The Impact Of The COVID-19 Pandemic On Hospital Admissions In The United StatesHealth Affairs, 2020
- HIV Care Experiences During the COVID-19 Pandemic: Mixed-Methods Telephone Interviews with Clinic-Enrolled HIV-Infected Adults in UgandaAIDS and Behavior, 2020
- Modelling the impact of COVID-19 on HIVThe Lancet HIV, 2020
- Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling studyThe Lancet Global Health, 2020
- HIV and risk of COVID-19 death: a population cohort study from the Western Cape Province, South AfricamedRxiv, 2020
- Rapid Implementation of Inpatient Telepalliative Medicine Consultations During COVID-19 PandemicJournal of Pain and Symptom Management, 2020
- Maintaining HIV care during the COVID-19 pandemicThe Lancet HIV, 2020